Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors

Johannes Clausen, David Nachbaur, Jutta Auberger et al.|Bone Marrow Transplantation|2011

Cited by 8